SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-037205
Filing Date
2019-06-24
Accepted
2019-06-24 16:17:27
Documents
3
Period of Report
2019-06-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-12060_18k.htm 8-K 27960
2 EX-3.1 a19-12060_1ex3d1.htm EX-3.1 42071
3 EX-3.2 a19-12060_1ex3d2.htm EX-3.2 153586
  Complete submission text file 0001104659-19-037205.txt   224745
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38944 | Film No.: 19915427
SIC: 2834 Pharmaceutical Preparations